GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SEEGENE Inc (XKRX:096530) » Definitions » Total Equity

SEEGENE (XKRX:096530) Total Equity : ₩1,043,183 Mil (As of Jun. 2024)


View and export this data going back to 2010. Start your Free Trial

What is SEEGENE Total Equity?

SEEGENE's total equity for the quarter that ended in Jun. 2024 was ₩1,043,183 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

SEEGENE Total Equity Historical Data

The historical data trend for SEEGENE's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SEEGENE Total Equity Chart

SEEGENE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 152,825.65 646,405.93 1,083,596.37 1,150,278.98 1,030,398.98

SEEGENE Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,059,734.78 1,043,750.91 1,030,398.98 1,025,176.52 1,043,182.88

SEEGENE Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

SEEGENE's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=1251451.914-221052.938
=1,030,399

SEEGENE's Total Equity for the quarter that ended in Jun. 2024 is calculated as

Total Equity=Total Assets(Q: Jun. 2024 )-Total Liabilities(Q: Jun. 2024 )
=1267641.674-224458.799
=1,043,183

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SEEGENE Total Equity Related Terms

Thank you for viewing the detailed overview of SEEGENE's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

SEEGENE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SEEGENE Inc (XKRX:096530) » Definitions » Total Equity
Comparable Companies
XKRX:085660 XKRX:016790 XKRX:141080 XKRX:064550 XKRX:298380 XKRX:005250 XKRX:214450 XKRX:950160 XKRX:950210 XKRX:087010 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Taewon Building 65-5 Bangyi-Dong, Songpa-gu, Seoul, KOR, 138-050
Website
http://www.seegene.co.kr
SEEGENE Inc is engaged in the healthcare sector. The Korean firm specializes in developing upgraded technology for accurate diagnosis of various diseases. Its products include pathogen inspection solutions such as respiratory, gastrointestinal, tuberculosis and meningitis pathogens.

SEEGENE Headlines

No Headlines